Cargando…
The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability
A combination of 3D printing techniques and synthetic biology, 3D bioprinting is a promising field. It is expected that 3D bioprinting technologies will have applications across an array of fields, spanning biotechnology, medical surgery and the pharmaceutical industry. Nonetheless, the progress of...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773692/ https://www.ncbi.nlm.nih.gov/pubmed/35053272 http://dx.doi.org/10.3390/biom12010124 |
_version_ | 1784636156466429952 |
---|---|
author | Althabhawi, Nabeel M. Zainol, Zinatul Ashiqin |
author_facet | Althabhawi, Nabeel M. Zainol, Zinatul Ashiqin |
author_sort | Althabhawi, Nabeel M. |
collection | PubMed |
description | A combination of 3D printing techniques and synthetic biology, 3D bioprinting is a promising field. It is expected that 3D bioprinting technologies will have applications across an array of fields, spanning biotechnology, medical surgery and the pharmaceutical industry. Nonetheless, the progress of these technologies could be hindered, unless there is adequate and effective protection for related applications. In this article, the authors examine the patent eligibility of 3D bioprinting technologies. This issue raises concern given that existing patent systems are generally averse to nature-derived inventions and many of them exclude products of nature or discoveries from patentability. This qualitative study analyses the current patent systems in key jurisdictions, particularly, the U.S. and the EU, and their applicability, as well as effectiveness, in the context of 3D bioprinting. The study argues that the main reason for the apathy of existing patent systems towards bio-inventions is that they were designed to deal with mechanical inventions. It suggests an innovation framework that encompasses both mechanical and biological inventions to cater adequately to emerging technologies. |
format | Online Article Text |
id | pubmed-8773692 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87736922022-01-21 The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability Althabhawi, Nabeel M. Zainol, Zinatul Ashiqin Biomolecules Review A combination of 3D printing techniques and synthetic biology, 3D bioprinting is a promising field. It is expected that 3D bioprinting technologies will have applications across an array of fields, spanning biotechnology, medical surgery and the pharmaceutical industry. Nonetheless, the progress of these technologies could be hindered, unless there is adequate and effective protection for related applications. In this article, the authors examine the patent eligibility of 3D bioprinting technologies. This issue raises concern given that existing patent systems are generally averse to nature-derived inventions and many of them exclude products of nature or discoveries from patentability. This qualitative study analyses the current patent systems in key jurisdictions, particularly, the U.S. and the EU, and their applicability, as well as effectiveness, in the context of 3D bioprinting. The study argues that the main reason for the apathy of existing patent systems towards bio-inventions is that they were designed to deal with mechanical inventions. It suggests an innovation framework that encompasses both mechanical and biological inventions to cater adequately to emerging technologies. MDPI 2022-01-12 /pmc/articles/PMC8773692/ /pubmed/35053272 http://dx.doi.org/10.3390/biom12010124 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Althabhawi, Nabeel M. Zainol, Zinatul Ashiqin The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability |
title | The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability |
title_full | The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability |
title_fullStr | The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability |
title_full_unstemmed | The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability |
title_short | The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability |
title_sort | patent eligibility of 3d bioprinting: towards a new version of living inventions’ patentability |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773692/ https://www.ncbi.nlm.nih.gov/pubmed/35053272 http://dx.doi.org/10.3390/biom12010124 |
work_keys_str_mv | AT althabhawinabeelm thepatenteligibilityof3dbioprintingtowardsanewversionoflivinginventionspatentability AT zainolzinatulashiqin thepatenteligibilityof3dbioprintingtowardsanewversionoflivinginventionspatentability AT althabhawinabeelm patenteligibilityof3dbioprintingtowardsanewversionoflivinginventionspatentability AT zainolzinatulashiqin patenteligibilityof3dbioprintingtowardsanewversionoflivinginventionspatentability |